Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT04262531 Completed - Critical Illness Clinical Trials

Body Composition Study in Critically Ill Patients

Start date: July 5, 2019
Phase:
Study type: Observational

This is a single-center prospective observational study that aimed to describe the trajectory of change in body composition among critically ill patients who were able to function independently prior to admission. Ultrasound measurement of the quadriceps muscle and bioelectrical impedance analysis will be conducted at baseline, day 7, day 14 and before ICU discharge. The relationship between the change of body composition and clinical outcomes, activities of daily living and quality of life at 6-month post ICU admission will be investigated. Further, the association between nutritional (energy and protein) intake and change in body composition will also be investigated.

NCT ID: NCT04261543 Recruiting - Critical Illness Clinical Trials

The Effect of High Protein and Early Resistance Exercise Versus Usual Care in Critically Ill Patients

EFFORT-X
Start date: August 5, 2019
Phase: N/A
Study type: Interventional

This is a 2-arm, parallel-group, randomized controlled trial that investigates the effect of combined high protein and early resistance exercise versus usual care on muscle mass, quality and strength, clinical outcomes, functional outcomes and quality of life in mechanically ventilated critically ill patients

NCT ID: NCT04252027 Completed - Clinical trials for Critically Ill Patients

Therapeutic Drug Monitoring of Fluconazole in Critically Ill Patients

Start date: April 23, 2019
Phase:
Study type: Observational

This prospective study will research the exposure and its variability to fluconazole after longitudinal administration in critically ill patients

NCT ID: NCT04247607 Recruiting - Critical Illness Clinical Trials

Specialized Treatment, Rehabilitation and Outcome in Patients With Prolonged Critical Illness

CritillPro
Start date: December 13, 2019
Phase:
Study type: Observational [Patient Registry]

This prospective observational study aims to describe the outcome for patients with persistent or chronic critical illness treated at Remeo, a clinic specialized for patients in need of prolonged intensive care and intensive care rehabilitation in Sweden. Patients' disease characteristics and the treatment in multidisciplinary patient centered teams for intensive care, weaning from mechanical ventilation and simultaneous rehabilitation will be described. Patients will be followed one year after discharge to document health related quality of life, physical function, frailty, mental illness and used health care resources.

NCT ID: NCT04242966 Withdrawn - Critical Illness Clinical Trials

The Effect of Higher Protein Dosing in Critically Ill Patients Ultrasound a Sub-study

EFFORTUS
Start date: November 1, 2020
Phase: Phase 3
Study type: Interventional

The investigators will evaluate the effects of of higher protein/amino acid dosing (≥2.2 g/kg/d) vs usual care of protein/amino acid dosing (≤1.2 g/kg/d) over muscle mass in nutritionally high risk ill patients.

NCT ID: NCT04239209 Completed - Critical Illness Clinical Trials

Effect of Intensivist Communication on Surrogate Prognosis Interpretation

Start date: September 27, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effect of physician communication styles on the interpretation of prognosis by family members of chronically-ill patients. Participants were randomized to view one of four videos how depicting different physicians disclose prognosis when physicians expect an ICU patient to die.

NCT ID: NCT04232956 Completed - Influenza Clinical Trials

Invasive Pulmonary Aspergillosis and Severe Influenza

ASPERGIGRIPP
Start date: July 27, 2018
Phase:
Study type: Observational

Invasive pulmonary aspergillosis (IPA) has been reported in critically ill patients with influenza infection with a highly variable incidence between 1 to 21%. Studies investigating IPA in critically ill patients with influenza infection suffer limitations in their methods. It remains unknown whether patients with influenza are more at risk of IPA than other patients hospitalized in intensive care unit and whether patients with influenza who develop IPA have specific risk factors for this infection. Our study aims to determine the incidence of IPA in a large multicenter cohort and to identify risk factors for IPA in these patients.

NCT ID: NCT04228380 Completed - Critical Illness Clinical Trials

Limitations and Mortality in Intensive Care

LIMO
Start date: March 1, 2020
Phase:
Study type: Observational

This is an observational prospective pilot-study that investigates which patient-related variables that predict a decision to limit life sustaining treatments. Some of the variables we were interested in cannot be accessed in registry data, such as frailty scale score and living at home or not. Furthermore we wanted to investigate if the variables that were independently associated with a decision to limit LST were different for critically ill patients with COVID-19 than for critically ill patients with other diagnoses in a Swedish intensive care unit during the pandemic.

NCT ID: NCT04227548 Completed - Clinical trials for Critical Illness Polyneuromyopathy

Reference Values for Compound Muscle Action Potential Amplitude Obtained by Direct Muscle Stimulation

Start date: April 30, 2019
Phase: N/A
Study type: Interventional

Direct muscle stimulation (DMS) method is one of the electrodiagnostic methods used in the diagnosis of critical illness myopathy (CIM) and critical illness neuropathy (CIN). The ratio of amplitude of compound muscle action potential (CMAP) obtained by nerve stimulation (nCMAP) to amplitude of CMAP obtained by DMS (dmCMAP) can be used to differentiate these two diseases. Although not certain, if the ratio is < 0.5, the diagnosis is thought to be consistent with CIN. The ratio > 0.5 is considered to be a finding supporting CIM. The investigators aimed to find the reference values of the ratio from healthy individuals. A monopolar needle electrode was used for DMS. The dmCMAP and nCMAP were recorded with a concentric needle. The ratio was calculated by using amplitudes of dmCMAP and nCMAP obtained from deltoid and tibialis anterior muscles.

NCT ID: NCT04224883 Recruiting - Critical Illness Clinical Trials

Effect of Different Feeding Method on Gastrointestinal Function of Critical Patients

DFM-GFC
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The intestine is the most vulnerable target organ in septic patients and is the first to be damaged organ in multiple organ dysfunction syndrome(MODS).Therefore, improving intestinal motility and mucosal barrier function is critical to the treatment of sepsis. Many studies have shown that, early enteral nutrition(EN) in patients with sepsis helps prevent and treat intestinal dysfunction, reducing ICU mortality and length of stay in ICU. However, there is little research on feeding methods. In this study the investigators will compare the outcomes of different feeding methods: continuously-pumped in 24 hours, continuouslypumped in 16 hours and intermittently-pumped through the stomach tube. The aim of this study is to investigate the effects of different feeding methods on intestinal function in septic patients.